Homology Medicines Inc (DELISTED) (FIXX:DL)
0.9347
-15.76
(-94.40%)
USD |
NASDAQ |
Mar 25, 16:00
0.92
-0.01
(-1.57%)
After-Hours: 20:00
Homology Medicines Cash from Operations (Quarterly): -21.58M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.58M |
| September 30, 2023 | -24.94M |
| June 30, 2023 | -23.66M |
| March 31, 2023 | -26.05M |
| December 31, 2022 | -27.20M |
| September 30, 2022 | -24.93M |
| June 30, 2022 | -30.85M |
| March 31, 2022 | -30.68M |
| December 31, 2021 | -30.43M |
| September 30, 2021 | -25.39M |
| June 30, 2021 | -24.11M |
| March 31, 2021 | -29.82M |
| December 31, 2020 | -11.61M |
| September 30, 2020 | -28.89M |
| Date | Value |
|---|---|
| June 30, 2020 | -27.99M |
| March 31, 2020 | -25.85M |
| December 31, 2019 | -26.33M |
| September 30, 2019 | -25.48M |
| June 30, 2019 | -21.67M |
| March 31, 2019 | -17.87M |
| December 31, 2018 | -8.079M |
| September 30, 2018 | -13.69M |
| June 30, 2018 | -9.747M |
| March 31, 2018 | -11.04M |
| December 31, 2017 | 22.05M |
| September 30, 2017 | -5.449M |
| June 30, 2017 | -5.595M |
| March 31, 2017 | -4.525M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-30.85M
Minimum
Jun 2022
-11.61M
Maximum
Dec 2020
-25.66M
Average
-25.85M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Societal CDMO Inc (DELISTED) | 1.527M |
| AgeX Therapeutics Inc (DELISTED) | -1.864M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 31.72M |
| Cash from Financing (Quarterly) | 0.014M |
| Free Cash Flow | -96.46M |
| Free Cash Flow Per Share (Quarterly) | -6.699 |
| Free Cash Flow Yield | -3.21K% |